Ajax-Loading

Merck & Company Inc - Cash and Equivalents

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cash-and-Equivalents" stands at 18.17 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Merck & Company Inc's third quarter, the item "Cash and Equivalents" stands at 18.17 Billion USD. This represents an increase of 126.91 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 24.50 percent compared to the value the year prior.
The 1 year change in percent is 24.50.
The 3 year change in percent is 63.02.
The 5 year change in percent is 147.00.
The 10 year change in percent is 140.71.

The Serie's long term average value is 10.00 Billion United States Dollars. It's latest available value, on 09/30/2025, is 81.62 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2018, to it's latest available value, on 09/30/2025, is +305.29%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Cash and Equivalents for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash and Equivalents905,699,262,464.00
LogoJohnson & Johnson - Cash and Equivalents486,508,953,600.00
LogoAbbVie Inc - Cash and Equivalents399,570,305,024.00
LogoRoche Holding AG - Cash and Equivalents317,433,206,677.55
LogoAstraZeneca PLC - Cash and Equivalents280,205,508,085.11